News

Many thanks to customers who presented at ISER 2023

Last week at the ISER 2023 biennal meeting, users of Imagine Eyes' retinal imaging devices have shared their work and findings…

Great presentations at the AO-Vision symposium !

Last week, rtx1 users presented their work in IRDs at the AO-vision symposium.

Imagine Eyes appoints Maelys Bellay as QA/RA specialist

Maelys Bellay recently joined our Quality Assurance and Regulatory Affairs (QA/RA) team at Imagine Eyes. “I am happy to…

Adaptive optics monitors photoreceptor response to therapy in multifocal choroiditis

Recently published in Retinal Cases & Brief Reports, a longitudinal case study describes the course of retinal alterations…

Imagine Eyes selected for Bpifrance accelerator program

We are happy to share that Imagine Eyes is laureate for a second accelerator program in less than one year! This month,…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…

Replay available – Webinar on AO imaging in AMD

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Retinal adaptive optics imaging goes multimodal

A publication in Nature Scientific Reports introduces a technology that delivers multimodal multiscale retinal images, developed by MERLIN - a collaborative project uniting Imagine Eyes, 3 academic teams and 2 clinical centers. It received financial support from the European Commission's Horizon 2020 program.

Great presentations at the rtx1 users’ e-symposium 2022! Replay available

Last week, we had the pleasure to host the rtx1 users’ e-symposium 2022, chaired by Prof. Paulo E. Stanga from The Retina Clinic London, and Dr. Daniela Bacherini from AOU Careggi Teaching Hospital in Florence.